About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

KYORIN Pharmaceutical Co.,Ltd.(4569) Summary

4569
TSE Prime
KYORIN Pharmaceutical Co.,Ltd.
1,453
JPY
+6
(+0.41%)
Dec 23, 3:30 pm JST
9.27
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.7
PBR
0.64
Yield
3.58%
Margin Trading Ratio
68.88
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
1,449 JPY 9.25 USD
Previous Close Dec 20
1,447 JPY 9.22 USD
High Dec 23, 3:07 pm
1,453 JPY 9.27 USD
Low Dec 23, 11:16 am
1,440 JPY 9.19 USD
Volume
87,200
Trading Value
0.13B JPY 0.81M USD
VWAP
1448.53 JPY 9.25 USD
Minimum Trading Value
145,300 JPY 927 USD
Market Cap
0.09T JPY 0.60B USD
Number of Trades
231
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Mid
1-Year Average
274
1-Year High Aug 5, 2024
841
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 500 113,500 227.00
Dec 6, 2024 800 124,600 155.75
Nov 29, 2024 700 117,800 168.29
Nov 22, 2024 1,700 117,100 68.88
Nov 15, 2024 500 127,700 255.40
Company Profile
KYORIN Pharmaceutical Co., Ltd. is a mid-tier pharmaceutical company. Its main products include asthma medications and expectorants. The company also produces generic drugs and gastrointestinal medicines.
Sector
Pharmaceuticals